Intra-procedural Transthoracic Echocardiogram for Heart Failure
(EC-LBBAP Trial)
Trial Summary
What is the purpose of this trial?
The goal of this observational study is to learn more about whether or not the use of heart ultrasound during pacemaker implantation is helpful. The main questions this aims to answer are: 1. Does this help the doctors with figuring out the wire location during implantation? 2. Does this reduce the wire placement procedure time? 3. Does this reduce the x-ray imaging time during the procedure? Participants will be asked to: 1. Have a physical exam and Echocardiogram (ECG) at initial visit, 2 weeks post implant, and 3 months post implant. 2. Have a urine pregnancy test (if applicable) 3. Have a heart ultrasound during implant procedure 4. Answer questions related to heart failure symptoms to see what stage of heart failure is present 5. Have device interrogation (a wand placed over the chest to see that the device is working properly) at a visit 2 weeks post implant and at 3 months post implant.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It is best to discuss this with the study coordinators or your doctor.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the study team or your doctor.
What data supports the idea that Intra-procedural Transthoracic Echocardiogram for Heart Failure is an effective treatment?
The available research shows that using echocardiography, a type of heart ultrasound, can help guide procedures like pacemaker implantation without the need for radiation. This is especially useful for certain patients, such as pregnant women. While the studies focus on different uses of echocardiography, they highlight its ability to provide real-time images, which can help doctors place devices more accurately and safely. This suggests that echocardiography can be an effective tool in heart procedures, offering advantages like avoiding radiation and detecting complications early.12345
What data supports the effectiveness of the treatment Intra-procedural Transthoracic Echocardiogram for Heart Failure?
A case study shows that transthoracic echocardiography (TTE) can guide pacemaker implantation without using fluoroscopy (X-ray guidance), which may be beneficial for certain patients, like pregnant women. This suggests that TTE can effectively assist in procedures involving the heart, potentially improving safety and outcomes.12345
What safety data exists for intra-procedural transthoracic echocardiogram in heart failure treatment?
The safety of intra-procedural transthoracic echocardiogram (TTE) has been demonstrated in various contexts. A case report showed the feasibility of using TTE to guide left bundle branch pacing without fluoroscopic guidance, suggesting it could be a safe alternative for pacemaker implantation, especially in pregnant women. Additionally, subcostal echocardiographic views have been used to guide the insertion of right ventricular temporary transvenous pacemakers, offering advantages such as rapid deployment, avoidance of radiation, and real-time visualization, which enhance safety by allowing early detection of complications. These studies indicate that TTE is a safe and effective tool in guiding cardiac procedures.13567
Is intra-procedural transthoracic echocardiogram safe for use in humans?
Intra-procedural transthoracic echocardiogram (a heart ultrasound) is generally considered safe for guiding procedures like pacemaker implantation and other cardiac interventions. It avoids radiation exposure and allows real-time visualization, which helps in early detection of potential complications.13567
Is the treatment in the trial 'Intra-procedural Transthoracic Echocardiogram for Heart Failure' a promising treatment?
How does the treatment using intra-procedural transthoracic echocardiogram for heart failure differ from other treatments?
Intra-procedural transthoracic echocardiogram for heart failure is unique because it uses real-time imaging to guide heart procedures, providing detailed images without the need for invasive techniques or general anesthesia. This approach can improve the precision and safety of heart failure treatments by allowing doctors to see the heart's structures and function during the procedure.23457
Research Team
Pugazhendhi Vijayaraman, MD
Principal Investigator
Geisinger Clinic
Eligibility Criteria
This trial is for patients needing a permanent pacemaker or ICD with conduction system pacing lead for slow heart rate or to coordinate heartbeats. They must be willing to follow the study's procedures and be available throughout its duration. It's not for those who can't consent, are pregnant, or in another study that could affect results.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Implant Procedure
Participants undergo pacemaker implantation with echocardiogram guidance
Post-Implant Follow-up
Participants have a physical exam, ECG, and device interrogation at 2 weeks and 3 months post-implant
Long-term Follow-up
Participants are monitored for long-term outcomes and procedural success
Treatment Details
Interventions
- Intra-procedural Transthoracic Echocardiogram
Find a Clinic Near You
Who Is Running the Clinical Trial?
Geisinger Clinic
Lead Sponsor
Medtronic
Industry Sponsor
Geoff Martha
Medtronic
Chief Executive Officer since 2020
Finance degree from Penn State University
Dr. Richard Kuntz
Medtronic
Chief Medical Officer since 2023
MD, MSc